Le Lézard
Classified in: Health
Subjects: PSF, CFG

Public Advisory - Fake Viagra seized from Jug City store in Scarborough, ON


OTTAWA, ON, April 26, 2024 /CNW/ -

Summary

Viagra (Back) (CNW Group/Health Canada (HC))

Viagra (Front) (CNW Group/Health Canada (HC))

Affected Products
Counterfeit Viagra, 100 mg sildenafil tablets

Issue
Health Canada has seized counterfeit Viagra from a Jug City store in Scarborough, Ontario (96 Dearham Wood). This is in addition to several other unauthorised sexual enhancement products seized from the same store.  

The counterfeit Viagra was sold in individual blister packs with no other packaging. Authorized Viagra is usually sold with an outer carton and a leaflet outlining the directions for use. Other indicators that the product is fake include an expiry date in an incorrect format ("EXP032 025") and no lot number printed on the blister pack.

Counterfeit drugs are made to look like authentic products, but they are not the same and they may not contain the drug at all. They can pose serious health risks if they contain a higher dosage than shown on the label, and could contain contaminants and hidden ingredients. Unlike authorized and authentic drug products, counterfeit drugs have not been assessed by Health Canada for safety, effectiveness, and quality. Selling counterfeit health products is illegal.

Health Canada has confirmed with the authorized manufacturer of Viagra that the seized product is counterfeit. Like authentic Viagra, the seized product is labelled to contain the prescription drug sildenafil. Sildenafil should be used only under the supervision of a health care professional. It should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerin) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure, and abnormal heartbeat. Other possible side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss.

Health Canada reminds consumers that the best way to make sure their prescription drugs are authentic is to buy them from a licensed pharmacy. Moreover, prescription drugs should be taken only under the advice and supervision of a health care professional because they are used to treat specific health conditions and may cause serious side effects. Prescription drugs can only be legally sold to consumers in Canada with a prescription and cannot be sold in convenience stores.

For more information regarding Health Canada's approach to counterfeit health products, please consult Health Canada's Policy on Counterfeit Health Products.

What you should do

Également disponible en français

SOURCE Health Canada (HC)


These press releases may also interest you

at 02:30
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...

at 02:10
Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883), a pioneering company developing innovative drugs for the treatment of rare genetic diseases, utilizing its proprietary CRISPR-based epigenome editing technology CRISPR-GNDM®, posted the...

at 02:00
Exams can be daunting for students and parents, but with the right approach it can become a rewarding and manageable experience. Expert private tutors can support academic study and exam-readiness while promoting students' mental health with...

at 02:00
As part of its Global Science Summit, the Novo Nordisk Foundation issues an international open call for research projects to catalyse science-based solutions to key global challenges. The programme expects to hand out up to eight grants with a total...

at 02:00
"Nando", a leading Lithuanian-owned biotechnology company known for its groundbreaking work in developing microbiological products for agriculture, that helped to save up to 50M on fertilisers, announces a significant bolstering of its...

at 01:27
GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual...



News published on and distributed by: